The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice

  1. Camille Dumon
  2. Diabe Diabira
  3. Ilona Chudotvorova
  4. Francesca Bader  Is a corresponding author
  5. Semra Sahin
  6. Jinwei Zhang
  7. Christophe Porcher
  8. Gary Wayman
  9. Igor Medina
  10. Jean-Luc Gaiarsa  Is a corresponding author
  1. Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), France
  2. Washington State University, United States
  3. University of Exeter Medical School, United Kingdom

Abstract

Brain computations rely on a proper balance between excitation and inhibition which progressively emerges during postnatal development in rodent. g-aminobutyric acid (GABA) neurotransmission supports inhibition in the adult brain but excites immature rodent neurons. Alterations in the timing of the GABA switch contribute to neurological disorders, so unveiling the involved regulators may be a promising strategy for treatment. Here we show that the adipocyte hormone leptin sets the tempo for the emergence of GABAergic inhibition in the newborn rodent hippocampus. In the absence of leptin signaling, hippocampal neurons show an advanced emergence of GABAergic inhibition. Conversely, maternal obesity associated with hyperleptinemia delays the excitatory to inhibitory switch of GABA action in offspring. This study uncovers a developmental function of leptin that may be linked to the pathogenesis of neurological disorders and helps understanding how maternal environment can adversely impact offspring brain development.

Data availability

All data generated or analyszed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 to 4 and Supplementary Figures 1 and 2.

Article and author information

Author details

  1. Camille Dumon

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Diabe Diabira

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Ilona Chudotvorova

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Francesca Bader

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    For correspondence
    francesca.bader@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
  5. Semra Sahin

    Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jinwei Zhang

    Institute of Biochemical and Clinical Sciences, University of Exeter Medical School, Exeter, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8683-509X
  7. Christophe Porcher

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Gary Wayman

    Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Igor Medina

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6839-5414
  10. Jean-Luc Gaiarsa

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    For correspondence
    jean-luc.gaiarsa@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7354-0559

Funding

National Institutes of Health (Grant MH086032)

  • Gary Wayman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Marlene Bartos, University of Freiburg, Germany

Ethics

Animal experimentation: All animal procedures were carried out in accordance with the European Union Directive of 22 September (2010/63/EU).

Version history

  1. Received: March 16, 2018
  2. Accepted: August 9, 2018
  3. Accepted Manuscript published: August 14, 2018 (version 1)
  4. Version of Record published: August 28, 2018 (version 2)
  5. Version of Record updated: December 4, 2018 (version 3)

Copyright

© 2018, Dumon et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,778
    views
  • 252
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Camille Dumon
  2. Diabe Diabira
  3. Ilona Chudotvorova
  4. Francesca Bader
  5. Semra Sahin
  6. Jinwei Zhang
  7. Christophe Porcher
  8. Gary Wayman
  9. Igor Medina
  10. Jean-Luc Gaiarsa
(2018)
The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice
eLife 7:e36726.
https://doi.org/10.7554/eLife.36726

Share this article

https://doi.org/10.7554/eLife.36726

Further reading

    1. Neuroscience
    Nicholas GW Kennedy, Jessica C Lee ... Nathan M Holmes
    Research Article

    How is new information organized in memory? According to latent state theories, this is determined by the level of surprise, or prediction error, generated by the new information: a small prediction error leads to the updating of existing memory, large prediction error leads to encoding of a new memory. We tested this idea using a protocol in which rats were first conditioned to fear a stimulus paired with shock. The stimulus was then gradually extinguished by progressively reducing the shock intensity until the stimulus was presented alone. Consistent with latent state theories, this gradual extinction protocol (small prediction errors) was better than standard extinction (large prediction errors) in producing long-term suppression of fear responses, and the benefit of gradual extinction was due to updating of the conditioning memory with information about extinction. Thus, prediction error determines how new information is organized in memory, and latent state theories adequately describe the ways in which this occurs.

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Katarzyna Marta Zoltowska, Utpal Das ... Lucía Chávez-Gutiérrez
    Research Article

    Amyloid β (Aβ) peptides accumulating in the brain are proposed to trigger Alzheimer’s disease (AD). However, molecular cascades underlying their toxicity are poorly defined. Here, we explored a novel hypothesis for Aβ42 toxicity that arises from its proven affinity for γ-secretases. We hypothesized that the reported increases in Aβ42, particularly in the endolysosomal compartment, promote the establishment of a product feedback inhibitory mechanism on γ-secretases, and thereby impair downstream signaling events. We conducted kinetic analyses of γ-secretase activity in cell-free systems in the presence of Aβ, as well as cell-based and ex vivo assays in neuronal cell lines, neurons, and brain synaptosomes to assess the impact of Aβ on γ-secretases. We show that human Aβ42 peptides, but neither murine Aβ42 nor human Aβ17–42 (p3), inhibit γ-secretases and trigger accumulation of unprocessed substrates in neurons, including C-terminal fragments (CTFs) of APP, p75, and pan-cadherin. Moreover, Aβ42 treatment dysregulated cellular homeostasis, as shown by the induction of p75-dependent neuronal death in two distinct cellular systems. Our findings raise the possibility that pathological elevations in Aβ42 contribute to cellular toxicity via the γ-secretase inhibition, and provide a novel conceptual framework to address Aβ toxicity in the context of γ-secretase-dependent homeostatic signaling.